EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) - Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that it will be presenting at the 2023 International Society for Organ Donation and Procurement ("ISODP") Organ Donation Congress [...]The post Miromatrix to Present at the 2023 ISODP Organ Donation first appeared on LifeCareNews.
Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.